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Parent Perception of Their Child’s Asthma Control and 
Concurrent Complementary and Alternative Medicine Use 
Michael D. Cabana, M.D., M.P.H.,1–3 Anurekha Gollapudi,1 Leah G. Jarlsberg,1 Megumi J. Okumura, M.D.,1 
Michelle Rait, M.A.,1 and Noreen M. Clark, Ph.D.4
We conducted a cross-sectional survey of 1322 parents of children with asthma to measure the prevalence and 
factors associated with complementary and alternative medicine (CAM) use for pediatric asthma. Multivariate 
regression techniques were used to determine factors associated with CAM use. Eleven percent (141/1322) of 
children were given CAM. Parents of children on daily medications who were perceived to have poor asthma 
control were almost three times more likely to use CAM than parents of children on no daily medications who 
were perceived to have high asthma control (risk ratio: = 2.81; confi dence interval: 1.72, 4.60); age, gender, race, 
income, and education level were not signifi cant independent predictors. Parent perception of asthma control is 
signifi cantly associated with CAM use. It is important for providers to elicit information regarding CAM use in 
the clinic, as this may imply that the asthma symptoms may not be well controlled.
Introduction
The use of complementary and alternative medicine (CAM), defi ned as practices, products and health-care 
systems that are not usually included or delivered in tra-
ditional medical systems,1 has become more prevalent for 
children.2 Studies have noted higher CAM use for children 
with asthma or respiratory symptoms.3,4 Furthermore, sev-
eral cross-sectional studies of CAM use for children with 
asthma in multicultural communities5–7 have reported a 
prevalence of CAM use as high as 89%. 
Given the prevalence of asthma and the increasing use 
of CAM, it is not unusual for primary care clinicians to deal 
with both issues. A key step in management is identifying 
CAM attitudes and practices and discussing how such ther-
apies may affect conventional asthma medicines. In some 
cases CAM interventions for asthma and allergic disease 
have been associated with increased hospitalizations,8 ad-
verse events,9 or potentially dangerous interactions of CAM 
therapies such as ephedra with albuterol causing cardiovas-
cular effects.10 Use of CAM may also potentially affect ad-
herence to conventional medical therapies.11 
Despite the importance of these issues, communication 
about CAM use is not ideal, as few health-care providers are 
aware of parent CAM use for their children.1,3,6 Furthermore, 
although motivations for adult patients to use CAM have 
been explored, there is relatively little understanding of the 
factors associated with and potential motivation for CAM 
use in children.
In this study, we interviewed a cross-section of parents 
of children with asthma to examine CAM use for pediatric 
asthma. Unlike previous studies, the families involved in 
this study represent a variety of practice settings (rural, 
urban, and suburban). The purpose of this study was to 
measure the prevalence of CAM use and the factors associ-
ated with CAM use for pediatric asthma. 
Materials and Methods
We analyzed baseline data from a randomized clinical 
trial designed to evaluate the effect of physician asthma edu-
cation on provider adherence to National Heart Lung and 
Blood Institute (NHLBI) guidelines for the management of 
asthma in children. The institutional review boards of the 
University of Michigan and the University of California, San 
Francisco approved the study protocol. Analyses from this 
dataset have been used to examine parent attitudes regard-
ing asthma management, as well as to validate a “Beliefs in 
Medications” questionnaire.12,13
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Patient population
We developed a registry of patients with asthma from the 
patient panels of pediatricians involved in the study. Project 
staff successfully contacted the adult—usually responsible 
for the child’s health-related care and who takes him/her to 
the doctor—of 3263 patients by telephone to invite further 
study participation, answer questions, obtain informed con-
sent, and screen for eligibility. Of the 3263 patients whose 
parents could be contacted, 1858 met eligibility criteria. 
Eligibility criteria included being the patient of a study 
physician, having a diagnosis of asthma and having utilized 
health-care services in the preceding 2 years, being between 
2 and 12 years of age, and having no other diseases asso-
ciated with pulmonary complications, such as tuberculosis, 
sickle cell disease, or cystic fi brosis. We included only one 
child per family. We excluded children if they had a parent 
who worked for a study physician or if children were under 
2 years of age, given that the diagnosis of asthma can be dif-
fi cult to establish before age 2.
Parents/guardians of 1322 of the 1858 eligible patients 
agreed to participate, yielding a response rate of 71.2%. 
Baseline interviews were conducted with these 1322 parents 
between May 2004 and April 2005.
Data collection
Trained interviewers administered the baseline sur-
vey to parents by telephone. The telephone interview aver-
aged 20 min in duration and was conducted in English for 
the majority of parents. It was also conducted in Spanish, 
Arabic, and Bengali in the relatively few instances when it 
was necessary. As part of this survey, parents were asked 
to provide demographic information including patient age, 
race, gender, and insurance type; the total annual combined 
household income in categories of ~$10,000 increments; the 
number of persons dependent on this income; and the high-
est level of school completed. To determine asthma sever-
ity, parents were asked about symptom frequency: (1) “In 
the past month, how many nights have symptoms such as 
coughing, wheezing, chest tightness, or shortness of breath 
interfered with (child’s) sleep?” and (2) “In the past month, 
how many days have symptoms such as coughing, wheez-
ing, chest tightness, or shortness of breath interfered with 
running, playing games or sports?”14
To determine the parents’ perception of their child’s cur-
rent asthma control, we asked parents to rate, “how con-
trolled has your child’s asthma been over the last month (28 
days)” using a scale from 1 to 5, where 1 was “not controlled 
at all” and 5 was “very controlled.”
Parents were asked to list each asthma medication cur-
rently prescribed by a physician. To gather data on the prev-
alence of use of complementary and alternative medicine, 
parents were also asked the following question: “In the 
past 12 months, have you used alternative home remedies, 
including herbs, teas, dietary changes, breathing exercises, 
meditation, prayer, massage, biofeedback, or homeopathy to 
control [your child]’s asthma symptoms?”
Classifi cation of CAM therapies
To classify parent responses into CAM categories, two 
investigators examined the verbatim responses of each 
of the parents who indicated use of alternative medicine 
using the National Institutes of Health National Center for 
Complementary and Alternative Medicine classifi cation sys-
tem (Table 1). These categories included alternative medical 
systems, mind–body interventions, biologically based ther-
apies, manipulative and body-based methods, and energy 
therapies. In a handful of cases, parents described two CAM 
therapies as a single therapy. In these cases, the therapy 
was classifi ed in relation to the initial therapy described. 
Responses that were consistent with conventional therapies 
for asthma (e.g., use of air fi lters, allergen avoidance, exer-
cise, etc.) were excluded from further classifi cation (Table 2). 
Although breathing exercises are used for vocal cord dys-
function associated with asthma, none of the patients in our 
sample reported this condition. 
Variables
Our dependent variable was the use of CAM for asthma. 
Independent variables included patient characteristics (age, 
gender, and severity of asthma), parent perception of the 
child’s asthma control, current asthma management (name 
and type of daily medication used), and caregiver character-
istics (age, ethnicity, race, location of birth, income, educa-
tion level, and insurance status). 
We dichotomized the level of caregiver education by col-
lapsing responses into one of two categories, “college gradu-
ate” versus “noncollege graduate.” The variable for race was 
collapsed into white and nonwhite. We used the defi nition 
of poverty published by the United States Department of 
Health and Human Services in 2004 to determine whether 
Table 1. Frequency of Complimentary and 
Alternative Medicine (CAM) Use, by Category
Type of CAM N (%)
Biologically based therapies 78 (42)
 Caffeine/coffee 6
 Essential oils 8
 Herbs 15
 Vitamin/mineral supplements 20
 Teas 27
 Other foods 2
Mind–body interventions 73 (39)
 Breathing exercises 23
 Creative visualization 1
 Meditation 3
 Prayer 40
 Relaxation techniques 4
 Yoga 2
Manipulative and body-based methods 24 (13)
 Chiropractor 8
 Contact refl exology 1
 Cranio-sacral therapy 3
 Massage 10
 Percussions 1
 Strain-counter-strain therapy 1
Alternative medical systems 12 (6)
 Homeopathy 12
 Energy-based methods 0
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household income was above or below the poverty level, 
adjusting for the number of household members dependent 
on the reported income.15 We created the following six cat-
egories: income less than the Federal Poverty Line (FPL), 
income greater or equal to the FPL and less than two times 
the FPL, income greater or equal to twice the FPL and less 
than three times the FPL, etc. until a category of income 
greater than fi ve times the FPL. 
We categorized each patient based on the use of a daily 
controller medication versus no daily controller medication. 
Controller medications included daily inhaled corticoster-
oids, leukotriene modifi ers, long-acting β-agonists, and 
combination medications.
Based on inspection of the data, we dichotomized the 
level of caregiver perception of their child’s asthma into one 
of two categories, “not controlled,” if they rated the child’s 
asthma control as 1–3; versus “controlled,” if they rated the 
child’s asthma control as 4 or 5.
Analysis
Categorical variables were compared using the χ2 statistic 
or, where expected cell counts were less than fi ve, Fisher’s 
exact test Table 3. Means of continuous variables (child 
age, caregiver age) were compared using Student’s t-test. 
Multivariate logistic regression was performed with use 
of CAM as the dependent variable, controlling for the fol-
lowing independent variables: child gender, use of a daily 
controller medicine, caregiver perception of asthma control, 
and caregiver age, race, place of birth, income relative to the 
poverty line, education, and insurance coverage. 
We used a generalized estimating equation (GEE) to con-
trol for correlated or clustered responses among patients of 
the same physician. All statistical analyses were performed 
using SAS Version 9.1 software (SAS Institute, Cary, NC). 
Statistical signifi cance was defi ned as p < 0.05.
Results
Characteristics of the 1322 children, their caregivers, and 
their households are presented in Table 3.
Frequency and perceived effects of CAM use
Of the 1322 children, 141 (10.7%) had been given CAM for 
their asthma in the last year. The 141 caregivers described 187 
different examples of CAM, for an average of 1.3 instances of 
CAM use for asthma per family. 
Table 1 provides categories of CAM use, the frequency 
with which each was cited, and examples. There were an 
additional 247 examples of therapies, initially described by 
parents as CAM (Table 2). However, these therapies did not 
fall into CAM defi nitions and were excluded from further 
analysis.
For the 187 examples of CAM use, in over two-thirds of 
the cases (68%), the therapy was self-recommended (Table 4). 
For 13% of cases of CAM use, caregivers stated that a med-
ical practitioner, not necessarily the child’s physician, had 
made the CAM recommendation. The high frequency of self-
 referral for CAM was consistent by type of CAM category.
When asked about the effects of CAM use, in 88% of 
instances of CAM use, caregivers reported a positive effect. 
Although in one-third of cases (68 of 187 cases) the positive 
effect was unspecifi ed, in many cases caregivers reported 
changes in relief of asthma or respiratory symptoms, a 
“calming effect” or a perception that the CAM use prevented 
future asthma exacerbations or symptoms.
Factors associated with CAM use
We explored an interaction between parent’s perception 
of the child’s asthma control and the use of a daily controller 
medication, as the likelihood of CAM use might be associ-
ated with the presence of poor asthma control, despite the 
use of a daily controller medication. In the adjusted model, 
using GEE to control for correlated responses among patients 
of the same physician, the single independent predictor of 
CAM use was the use of a daily medication with perceived 
poor asthma control [odds ratio (OR): 2.81; 95% confi dence 
interval (CI): 1.72, 4.60]. No other demographic characteris-
tics were associated with CAM use for asthma (Table 5).
We repeated our analysis with the use of biologically-
based CAM (e.g., herbs, teas, and supplements) for asthma as 
the dependent variable. This type of CAM use may be more 
likely to be implicated for interactions with conventional 
asthma therapies. In this model, increasing age of the patient 
(OR: 1.11; 95% CI: 1.05, 1.17), in addition to the use of a daily 
asthma controller with perception of poor asthma control 
(OR: 2.26; 95% CI: 1.09, 4.68), was associated with increased 
likelihood of CAM use. No other variables were signifi cant.
Discussion
In our sample, one in nine parents with a child with 
asthma reported CAM use within the last year. In addition, 
no demographic factors were associated with CAM use for 
Table 2. Therapies Described by Families, but not 
Included in Complimentary and Alternative 
Medicine Taxonomy
Therapies N (%)
Allergen avoidance (no pets, frequent cleaning) 19
Improved air quality (HEPA fi lters) 17
Climate control
 Humidifi er/vaporizer 38
 Dehumidifi er 2
 Cold air/vapor (puts head in freezer) 12
 Warm baths, showers, steam 64
 Moved (different home or school) 2
 Unspecifi ed 4
Dietary changes
 Eliminations (dairy, fat, Tefl on, pesticide) 12





 Nonprofessional massage 4
 Pounding 1
 Posture adjustments (propping up on pillows) 4
Other (hot water bottle, warm towels) 2
Over-the-counter medicines 42
HEPA, high effi ciency particulate air.
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et al. reported a higher prevalence of CAM use for asthma 
compared to our analysis (65% versus 11%, respectively) 
in a population from a similar but smaller cross-section of 
settings,18 our analyses excluded over-the-counter medica-
tions as a type of biologically based CAM.
In multivariate analysis, we found that no demographic 
factors are associated with parental report of CAM use for 
their child. One reason may be the broad defi nition of CAM, 
which ranges from mind–body interactions (e.g., prayer, etc.) 
to biologically based interventions (e.g., herbs, etc). We re-
peated the analyses with CAM use limited to only biolog-
ically based interventions and found no overall  difference 
in our results.
Another factor that may explain why CAM use is also 
independent of demographic characteristics was the fact 
that we controlled for parent perception of asthma control. 
Parental perception of asthma control is independent of any 
demographic characteristic, and is a refl ection of the under-
lying asthma severity and the perceived success of current 
management.19 
Furthermore, there was effect modifi cation of the per-
ception of asthma control through an interaction with the 
child’s current use of daily asthma medications. If par-
ents perceive that their child’s asthma control is poor and 
the child was already taking a daily asthma medication, 
the likelihood of CAM use for asthma was signifi cantly 
increased, more than each single factor alone. This fi nding 
is similar to patterns observed for older patients, as adults 
with self-reported poorer health status were more likely to 
use CAM.20
asthma. As a result, health-care providers should not make 
assumptions about which families use CAM, but instead 
evaluate potential CAM use in all families. We also found 
that one factor that is associated with CAM use is the parent 
perception of control of asthma symptoms. If parents’ per-
ceive that their child’s asthma control is poor and the child 
is already taking a daily asthma medication, the likelihood 
of CAM use for asthma is signifi cantly increased.
Our estimates of CAM use for asthma are less than other 
reported studies.5–7 However, although these studies also 
focused on children with asthma, the samples were drawn 
from single, multicultural communities within large cities. 
Our estimate of CAM use for asthma is consistent with other 
broader, representative samples.16,17 Our sample was drawn 
from three counties in Southeastern Michigan, which offer 
a cross-section of different practice settings (rural, sub-
urban, urban, and small cities). Although Sidora-Arcoleo 
Table 3. Use of Complimentary and Alternative Medicine (CAM) by Caregiver 
and Household Characteristics
 Used CAM N (%)
Bivariate, unadjusted 
RR (95% CI)
Caregiver age (odds per 5 additional years) 38.7 ± 7.4 1.06 (0.94–1.20)
Caregiver ethnicity (n = 1317)
 Hispanic/Latino origin 2/35 (6) 0.53 (0.14–2.04)
 Not of Hispanic/Latino origin 139/1282 (11)
Caregiver race (n = 1303)
 Asian 7/36 (19) 2.27 (0.97–5.30)
 Black 26/161 (16) 1.81 (1.13–2.88)
 Other/mixed 6/57 (11) 1.10 (0.46–2.64)
 White 101/1049 (10) Reference
Caregiver place of birth (n = 1321)
 Foreign born 10/86 (12) 1.10 (0.60–2.01)
 US born 131/1235 (11)
Primary language at home (n = 1321)
 English 138/1279 (11) 1.51 (0.50–4.55)
 Other 3/42 (7)
Mean household income level (odds per 
each multiple over the FPL)
4.2 ±1.7 0.89 (0.80–0.99)
Education level (n = 1315)
 Some college/AA/trade school or less 78/686 (11) 1.14 (0.83–1.55)
 College graduate or more 63/629 (10) Reference
Insurance coverage (n = 1307)
 No insurance/self-pay 0/18 (0) 0.25 (0.02–3.84)
 Medicaid 23/187 (12) 1.16 (0.76–1.77)
 Private or other insurance 118/1114 (11) Reference 
CI, confi dence interval; FPL, Federal Poverty Line; RR, risk ratio.
Table 4. Source of Complimentary and Alternative 




Medical practitioner 25 (13)
Other 30 (16)
Missing 4 (2)
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These fi ndings have implications for clinical care. The 
NHLBI guidelines recommend that physicians develop a 
partnership with families and attempt to screen for parent 
concerns about asthma.15 For example, health-care provid-
ers can ask, “how well controlled do you think your child’s 
asthma is?” If the level of asthma control is a concern, health-
care providers can initiate further management and develop 
a concrete plan to specifi cally address this issue. Studies 
suggest that use of simple, direct communication techniques 
to address parent questions and improve adherence do not 
necessarily require additional clinician time during the 
visit.21 If parent concerns are not addressed, there is a lower 
likelihood of adherence.22 This study would also suggest 
that such parents may be more likely to try CAM therapies 
for their child’s asthma. In two-thirds of cases, CAM use for 
asthma was initiated by the parents themselves.
Limitations
Despite the cross-section of practice settings in our 
sample, our data were only from Southeastern Michigan, 
which may not be generalizable. We did not collect informa-
tion about previous parental CAM self-use, which has been 
shown to be associated with parental use of CAM for their 
children. Although this variable is not in our analyses, it is 
unlikely to affect key variables in the analyses, such as par-
ent perception of asthma severity or physician prescription 
of a daily asthma controller medication.
Finally, according to the NHLBI guidelines, asthma 
control is based on objective pulmonary function tests, as 
well as parent description of symptom frequency.14 In addi-
tion, with there are other questionnaires to systematically 
assess asthma control,19 we did not collect lung function 
data or utilize other questionnaire methods. As a result, we 
were unable to correlate patient perception of control with 
Table 5. Logistic Regression Model: Odds of 






Child age (odds per additional year) 1.03 (0.99–1.07)
Daily meds × perception of control
 On daily meds, symptoms not 
controlled 
2.81 (1.72–4.60)
 No daily meds, symptoms not 
controlled 
1.53 (0.64–3.64)
 On daily meds, symptoms controlled 1.38 (0.96–1.97)
 No daily meds, symptoms controlled Reference
Caregiver income level 0.90 (0.80–1.00)
Education level
 High school graduate or less 0.72 (0.40–1.30)
 Some college or more Reference
Caregiver race 
 Asian 1.50 (0.45–5.03)
 Black 1.50 (0.85–2.66)
 Other/mixed 1.12 (0.38–3.29)
 White Reference
CI, confi dence interval; Meds, medicines; OR, odds ratio.
objective severity measures or other measures of asthma 
control.
Conclusions
This study offers additional insight into potential moti-
vation for parent use of CAM for their children, as parent’s 
perception of asthma control is signifi cantly associated with 
CAM use. In developing a rapport with parents, it is im-
portant to elicit parent concerns and address perceptions 
of asthma control. No demographic factors were associated 
with general CAM use. As a result, health-care providers 
should not make assumptions and should screen and assess 
all families about potential CAM use, as well as be pre-
pared to address how CAM use may affect current asthma 
management.
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